Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 2,801–2,900 of 3,349
Pulmonary B cells ameliorate Alzheimer’s disease-like neuropathologyPreprint
Feng, W., Zhang, Y., Wang, T., Wang, Z., Chen, Y., Sheng, C., Zou, Y., Pang, Y., Gao, J., Zhang, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.23.393942
Koch, B. M. E. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7716
Shi, Q., Sun, T., Zhang, Y., Power, C., Hoesch, C., Antonelli, S., Schroeder, M. K., Caldarone, B. J., Taudte, N., Schenk, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.15.426806
“Microglia have been shown to be highly phagocytic and participate in synapse elimination during aging and AD [31, 41].”
BackgroundSelf-citationFeng, X., Frias, E. S., Paladini, M. S., Chen, D., Boosalis, Z., Becker, M., Gupta, S., Liu, S., Gupta, N., & Rosi, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/794354
Complementing Subarachnoid Hemorrhage
van Dijk, B. J. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/210
The Longitudinal Relationships between Biomarkers of Alzheimer’s Disease
Krance, S. H. (2019) · TSpace (University of Toronto)
CR3 ruffles FcγR’s claim over phagocytic cups
Frautschy, S. A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100801 · Cited by 1
“CR3 can have important constitutive roles in the clearance of protein aggregates, including beta-amyloid and tau tangles (8, 9).”
BackgroundChen, J., Mao, K., Yu, H., Wen, Y., She, H., Yang, L., Zhang, H., Li, H., Wu, X., Ren, Y., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-131694/v1
Lockhart, E. F., Dolcetti, F. J. C., Herrera, M. L., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-638414/v1
Immortalized Human Conjunctival Epithelial Cells Produce Functional Complement C3 and C4 Proteins
Ziemanski, J. F., & Szalai, A. J. (2023) · Cornea · doi:10.1097/ico.0000000000003432
Jadhav, V. (2021) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2086
Li, C., Liu, K., Zhu, J., & Zhu, F. (2021) · Research Square · doi:10.21203/rs.3.rs-789627/v1
Microglia, TREM2, and Therapeutic Methods of Alzheimer’s Disease
Xu, S., Ji, Y., Sha, T., & Li, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100203
“In AD pathology, microglia also prove to be phagocytose synapses [23, 24].”
BackgroundRoy, E. R., Chiu, G. S., Li, S., Propson, N. E., Zheng, H., & Cao, W. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.01.466525
Self-citationΔιερεύνηση τεχνικών παραμέτρων για βέλτιστη σχεδίαση συστημάτων τεχνολογίας Wi-Fi
Papadakos, C. (2013) · Νημερτής
A sesenta y cinco años de "El Malestar en la Civilización", de Sigmund Freud
Quintana, A. C. (2004) · Dialnet (Universidad de la Rioja)
Immunopharmacology of Alzheimer’s disease
Nissar, K., Firdous, P., Ali, S., & Hussain, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90053-9.00014-2
Sims, S. G. (2021) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.10189
A neuron, microglia, and astrocyte triple coculture model to study Alzheimer diseasePreprint
Luchena, C., Zuazo-Ibarra, J., Valero, J., Matute, C., Alberdi, E. M., & Capetillo‐Zarate, E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.13.472367
“Both microglia and astrocytes can participate in synaptic elimination via the complement system (Hong et al., 2016) and MEGF10/MERTK pathways (Chung et al., 2013), respectively.”
BackgroundSmith, B. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735893194.793562731
Perspective Chapter: Alzheimer - A Complex Genetic Background
Calabrò, M., & Crisafulli, C. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101455
White matter integrity of the frontal brain and its relevance for catatonia and executive function
Arinrad, S. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8974
Biundo, F., Chiţu, V., Tindi, J. O., Burghardt, N. S., Shlager, G. G. L., Ketchum, H. C., Deture, M. A., Dickson, D. W., Wszolek, Z. K., Khodakhah, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.21.481325
Attwell, D., & Madry, C. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734066247.793551885
Kano, M., & Watanabe, T. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733168960.793562671
Kano, M., & Watanabe, T. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734198247.793562677
VanDusen, K. W., Qi, W., Li, Y.-J., Cai, V., Hall, A., Hiles, S., Thompson, J. W., Moseley, M. A., Hu, J. H., Cooter, M. L., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-35959/v1
Fischer, T. (2020) · Wiley eBooks · doi:10.1002/9780470015902.a0000173.pub3
Gould, E. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727795770.793537494
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811351-6.00026-7
Kipnis, J., & Mesquita, S. D. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734935594.793556877
Alzheimer’s disease as a syndrome of overloaded amyloidic synaptic tagging in memory networksPreprint
Murphy, N. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/7gsaz
Loss of region-specific glial homeostatic signature in prion diseasesPreprint
Makarava, N., Chang, J. C., Molesworth, K., & Baskakov, I. V. (2019) · Research Square · doi:10.21203/rs.2.17016/v1 · Cited by 2
“Growing 485 evidence suggest that similar mechanisms of synapse elimination are activated in reactive 486 microglia in neurodegenerative diseases including Alzhemer’s diseases, frontotemporal dementia 487 as well as normal aging [97-100].”
BackgroundKano, M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735998030.793570314
Ding, L., Chu, W., Xia, Y., Ming, S., Li, T., Zhou, F., & Deng, D. Y. B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.23.461600 · Cited by 1
Li, C., Liu, K., Zhu, J., & Zhu, F. (2021) · Research Square · doi:10.21203/rs.3.rs-706739/v1
Pasterkamp, R. J., & Raj, D. D. A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734066247.793553635
Pulmonary B Lymphocytes Ameliorate Alzheimer's Disease-Like NeuropathologyPreprint
Feng, W., Zhang, Y., Wang, T., Li, Q., Wang, Z., Zou, Y., Sheng, C., Chen, Y., Pang, Y., Ding, F., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-713746/v1
Zilles, K., & Palomero‐Gallagher, N. (2020) · doi:10.1093/med/9780198713005.003.0011
Tanaka, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735447386.793559189
Role of C1q in spleen-derived neutrophil infiltration and neuroinflammation after ICH in micePreprint
Tang, J., Luo, T., Geng, J., Zhang, B., Niu, Y., Wang, L., Jila, S., Feng, H., Zhu, G., & Chen, Z. (2019) · doi:10.21203/rs.2.18353/v1
“C1q interacts directly with damaged neurons and unwanted synapse in an antibody independent way, leading to inflammation and synaptic removal by macrophages and microglia [44].”
BackgroundPradhan, A. K., Shi, Q., Tartler, K. J., & Rammes, G. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.09.491159
Self-citationRodriguez-Rodriguez, P., Arroyo-García, L., Li, L.-C., Tsagkogianni, C., Wang, W., Salas-Allende, I., Plautz, Z. R., Cedazo-Mínguez, A., Sinha, S. C., Troyanskaya, O., et al. (2022) · bioRxiv · doi:10.1101/2022.05.14.491965
“Indeed, RT-qPCR on EC lysates showed a significant increase in expression of the microglia markers Cx3cr1, Itgam (that codes for CD11b) and complement C1qa (associated with synaptic pruning) (Lui et al., 2016; Vasek et al., 2016).”
BackgroundMartín‐Flores, N., Podpolny, M., McLeod, F., Workman, I., Crawford, K., Ivanov, D. K., Leonenko, G., Escott‐Price, V., & Salinas, P. C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.16.495307
“J20 mice exhibit excitatory synapse loss in the hippocampus at 4-months of age (early stage), whereas plaque deposition starts around 5-months and is widely distributed in the cortex and hippocampus by 9-months (late stage) (Hong et al., 2016; Meilandt et al., 2009; Mucke et al., 2000a, 2000b).”
BackgroundResultNeuroinflammation triggers microglial phagocytosis of synapses via induction of synaptic filopodiaPreprint
Cangalaya, C., Wegmann, S., Sun, W., Diez, L., Gottfried, A., Richter, K., Stoyanov, S., Pakan, J. M. P., Fischer, K., & Dityatev, A. E. (2022) · Research Square · doi:10.21203/rs.3.rs-1795055/v1
Acupuncture Treatment for Multiple Sclerosis
Wang, J., & Wu, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-96221-0_20
Chernyaeva, L., Ratti, G., Teirilä, L., Rankka, U., Fudo, S., Pelkonen, A., Korhonen, P., Leskinen, K., Keskitalo, S., Salokas, K., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4163140
Guo, K., Qi, F., Zuo, Z., Hu, K., Wang, R., Wu, T., Liu, H., Tang, J., Wang, Q., Xie, Y., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1906482/v1
Alzheimer disease and neuroinflammation in Down syndrome
Ganguly, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90456-8.00014-4
NEURON-ASTROCYTE INTERACTIONS IN NORM AND IN ALZHEIMER’S DISEASE
Vasilenko, S. A., Govorukha, D. A., & Kaurov, M. M. (2022) · Научное обозрение Медицинские науки (Scientific Review Medical Sciences) · doi:10.17513/srms.1278 · Cited by 1
Alia, A. O., Popovic, J., Salvo, M. A., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2058248/v1
Gene-dosage imbalance due to trisomic HSA21 and genotype–phenotype association in Down syndrome
Ganguly, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90456-8.00005-3
Development of specific phenotypes and genetic consequences in Down syndrome
Ganguly, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90456-8.00002-8 · Cited by 3
Ng, A. N., Salter, E. W., Georgiou, J., Bortolotto, Z. A., & Collingridge, G. L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.24.513427
Ding, L., Chu, W., Xia, Y., Ming, S., Li, T., Luo, L., Zhou, F., & Deng, D. Y. B. (2022) · Research Square · doi:10.21203/rs.3.rs-2320747/v1
Fagiani, F., Fülöp, T., Govoni, S. M., & Lanni, C. (2023) · Biomedicines · doi:10.3390/biomedicines11020484
“These results are intriguing taking into account that in the first stages of AD an unexpected pathological role for microglia has been involved [63].”
ResultA Communicative Approach for Foreign Language Learning via Social Media
Petrova, Y. (2023) · Lecture notes in networks and systems · doi:10.1007/978-3-031-26783-3_39 · Cited by 2
Reply to: “Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology‐Specific”
Lan, G., & Guo, T. (2023) · Annals of Neurology · doi:10.1002/ana.26639
(2018) · Society for Neuroscience eBooks · doi:10.1523/hon.010001
A novel miR-99b-5p- Zbp1 pathway in microglia contributes to the pathogenesis of schizophreniaPreprint
Kaurani, L., Islam, R., Heilbronner, U., Krüger, D. M., Zhou, J., Methi, A., Strauß, J., Pradhan, R., Burkhardt, S., Peña, T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.21.533602
Structure and Function of the Leukocyte Integrin αMβ2
Andersen, G. R., & Emsley, J. (2023) · Biology of extracellular matrix · doi:10.1007/978-3-031-23781-2_11 · Cited by 1
Activation of complement: A potent biomarker in multiple sclerosis
Sadeghmousavi, S., & Rezaei, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18578-6.00013-1
Roles of Purinergic Receptors in Alzheimer’s Disease
Delarasse, C., & Blum, D. (2023) · Springer eBooks · doi:10.1007/978-3-031-26945-5_8
The molecular neural mechanism underlying the acceleration of brain aging due to Dcf1 deficiency
Zhou, H., Wang, J., & Wen, T. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103884
Amyloidosis and ageing have differential effects on microglial Ca 2+ activity in the mouse brainPreprint
Izquierdo, P., Jolivet, R., Attwell, D., & Madry, C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.10.552670
Bo, W., Cheng, G., Li, L., Sun, Q., Bi, Q., Lu, C. C., Yin, C., Chen, N., Hu, M., Lu, H., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.29.555298
The complement system in zebrafish tissue regeneration
Keller, L. (2022) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.74983
Baker, K., & Dalley, J. W. (2023) · Brain and Neuroscience Advances · doi:10.1177/23982128231199006
“This has been shown in mice in some really elegant work by Beth Stevens and Soyen Hong (Hong et al., 2016).”
ResultKUŞAT, T., & Emrah, S. U. R. (2023) · doi:10.59287/sbyc.582
Martín‐Flores, N., Podpolny, M., McLeod, F., Workman, I., Crawford, K., Ivanov, D. K., Leonenko, G., Escott‐Price, V., & Salinas, P. C. (2023) · eLife · doi:10.7554/elife.89453.1 · Cited by 3
Multiomic Phagosome Profiling as a New Tool to Study Human Microglia BiologyPreprint
Wogram, E., Sümpelmann, F., Dong, W., Rawat, E. S., Fernández-Maestre, I., Fu, D., Braswell, B., Khalil, A. S., Buescher, J. M., Borner, G. H. H., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4585843
ALZHEİMER HASTALIĞINDA KOMPLEMAN SİSTEMİN ROLÜ
Yirün, A., KÖSE, S. B. E., & Erkekoğlu, P. (2023) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1337722
Grigoletti-Lima, G. B. (2020) · doi:10.47749/t/unicamp.2020.1167784
The ubiquitin-proteasome system in neurodegenerative diseases: Lessons from mutant ubiquitin
Verheijen, L. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231024lv · Cited by 1
Immunogenetics of Alzheimer’s disease: the human leukocyte antigen
Costescu, C., Vică, L. M., Bâlici, Ș., Nicula, G. Z., Nemeş, B., Coman, H. G., & Matei, H. V. (2023) · Psihiatru ro · doi:10.26416/psih.75.4.2023.8928
Microglia in the pathology of Alzheimer's disease
Wang, Y. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/22/20230968
Mallah, K., Krieg, C., Toutonji, A., Borucki, D. M., Hatchell, D., Couch, C., Hardiman, G., Kobeissy, F. H., Guglietta, S., & Tomlinson, S. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4782545
Yuen, S. C., Liang, X., Zhu, H., Jia, Y., & Leung, S.-W. (2021) · Figshare · doi:10.6084/m9.figshare.14945066
Stoner, A. J., Fu, L., Nicholson, L., Zheng, C., Toyonaga, T., Spurrier, J. M., Laird, W., Cai, Z., & Strittmatter, S. M. (2023) · Figshare · doi:10.6084/m9.figshare.24571848
Chen, S., Chang, Y., Li, L., Acosta, D., Li, Y., Guo, Q., Wang, C., Turkes, E., Morrison, C. T., Julian, D. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601026
Chen, S., Chang, Y., Li, L., Acosta, D. M., Li, Y., Guo, Q., Wang, C., Turkes, E., Morrison, C. T., Julian, D. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601020
Yuen, S. C., Liang, X., Zhu, H., Jia, Y., & Leung, S.-W. (2021) · Figshare · doi:10.6084/m9.figshare.14945063
Boeddrich, A., Haenig, C., Neuendorf, N., Blanc, E., Ivanov, A., Kirchner, M., Schleumann, P., Bayraktaroğlu, I., Richter, M., Molenda, C., et al. (2023) · DZNE Pub · doi:10.6084/m9.figshare.23714235
Chen, S., Chang, Y., Li, L., Acosta, D. M., Li, Y., Guo, Q., Wang, C., Turkes, E., Morrison, C. T., Julian, D. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601017
Chen, S., Chang, Y., Li, L., Acosta, D., Li, Y., Guo, Q., Wang, C., Turkes, E., Morrison, C. T., Julian, D. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601011
Chen, S., Chang, Y., Li, L., Acosta, D. M., Li, Y., Guo, Q., Wang, C., Turkes, E., Morrison, C. T., Julian, D. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601014
Chen, S., Chang, Y., Li, L., Acosta, D. M., Li, Y., Guo, Q., Wang, C., Turkes, E., Morrison, C. T., Julian, D. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601032
Bai, B., Vanderwall, D., Li, Y., Wang, X., Poudel, S., Wang, H., Dey, K. K., Chen, P., Yang, K., & Peng, J. (2021) · Figshare · doi:10.6084/m9.figshare.15162179
Yuen, S. C., Liang, X., Zhu, H., Jia, Y., & Leung, S.-W. (2021) · Figshare · doi:10.6084/m9.figshare.14945060
Chen, S., Chang, Y., Li, L., Acosta, D., Li, Y., Guo, Q., Wang, C., Turkes, E., Morrison, C. T., Julian, D. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601023
Chen, S., Chang, Y., Li, L., Acosta, D. M., Li, Y., Guo, Q., Wang, C., Turkes, E., Morrison, C. T., Julian, D. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601029
LRRK2 regulates synaptic function through modulation of actin cytoskeletal dynamics
Tombesi, G., Kompella, S. N., Favetta, G., Chen, C., Ornaghi, M., Zhao, Y., Morosin, E., Sevegnani, M., Lama, A., Marte, A., et al. (2024) · eLife · doi:10.7554/elife.95987 · Cited by 1
A C1q immunfehérje interakcióinak vizsgálata és fehérjealapú gátlása
Vadászi, H. (2023) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2022.131
Ito, S., Yamauchi, K., Hama, H., Koike, M., Miyawaki, A., & Hioki, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.25.591057
“These mice overproduce pathogenic Aβ peptides and exhibit several key features of AD, such as age-dependent impairments in learning and memory, synaptic deficits, aberrant neuronal network activity, formation of Aβ plaques, and neuroinflammatory responses of astrocytes and microglia 12,14,15 .”
BackgroundMicroglia Development and Function in the Eye
Abdulwahab, Q., Tarachand, S. P., & Samuel, M. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13820-1.00059-1
Ugursu, B., & Wolf, S. A. (2024) · doi:10.3791/66639-v
Hikosaka, M., Hosoi, N., Yang, M.-S., Lian, Y., Hirai, H., Kitada, M., Narumiya, S., & Ohtsuki, G. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4854179
Axon length-dependent synapse loss is mediated by neuronal cytokine-induced glial phagocytosisPreprint
Tenedini, F. M., Yin, C., Huang, J. Y., Dhiman, N., Soba, P., & Parrish, J. Z. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.09.598122
“Intriguingly, activation of the innate immune system, including the mammalian complement system (CS), has been implicated in excessive synaptic pruning in AD ( 113 – 117 ) .”
BackgroundHugging it out: Targeting oxytocin in alzheimer’s disease
Koulousakis, P. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20240523pk
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.